- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Oncology Research and Treatment ; 25 (2002), 6. - S. 534-539. - ISSN 2296-5270. - eISSN 2296-5262
- Klassifikation
-
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Konstanz
- (wer)
-
Bibliothek der Universität Konstanz
- (wann)
-
2002
- Urheber
- URN
-
urn:nbn:de:bsz:352-2-19cu8xfa46h7a3
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gillessen, Silke
- Groettrup, Marcus
- Cerny, Thomas
- Bibliothek der Universität Konstanz
Entstanden
- 2002
Ähnliche Objekte (12)
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L
The ubiquitin-like modifier FAT10 in cancer development
Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?
The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition
Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L
The ubiquitin-like modifier FAT10 in cancer development
Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?
The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition
Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation
PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
The ubiquitin-like modifier FAT10 : much more than a proteasome-targeting signal
Advances in Prostate Cancer Immunotherapies
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition
Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L
The ubiquitin-like modifier FAT10 in cancer development
Interferon-γ inducible exchanges of 20S proteasome active site subunits : why?
The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition
Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome
Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome
Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation